✦ LIBER ✦

Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: Lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists

✍ Scribed by Wojciech Mazur; Grzegorz L. Kaluza; Shelly Sapp; Craig Balog; Eric J. Topol; Daniel B. Mark; Stephen G. Ellis; Dean J. Kereiakes; A.Michael Lincoff; Neal S. Kleiman

Book ID: 117842772
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 105 KB
Volume: 143
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2002.121519

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Promise of combined low-molecular-weight

Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: Results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)

✍ Debabrata Mukherjee; Kenneth W. Mahaffey; David J. Moliterno; Robert A. Harringt 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Bleeding risk of platelet glycoprotein I

Bleeding risk of platelet glycoprotein IIb/IIIa receptor antagonists in broad-based practice (results from the Society for Cardiac Angiography and Interventions Registry)

✍ Phillip A Horwitz; Jesse A Berlin; William H Sauer; Warren K Laskey; Ronald J Kr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Complementary effects of thienopyridine

Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; Results from the ESPRIT trial

✍ Jean-Pierre Dery; Mark E. Campbell; Jasmine Mathias; Karen S. Pieper; Robert A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Outcome of acute ST-segment elevation my

Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIB/IIIA inhibition: lessons from the GUSTO V Trial

✍ H.S Gurm; A.M Lincoff; D Lee 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Outcome of acute ST-segment elevation my

✍ Hitinder S. Gurm; A.Michael Lincoff; David Lee; W.H.Wilson Tang; Gang Jia; Joan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 114 KB

The vulnerable endothelium: Priming the

The vulnerable endothelium: Priming the vascular endothelium for thrombosis with unfractionated heparin: Biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial

✍ Richard C. Becker 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 79 KB